ARCHIVES

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

This article is from The Cancer Letter archive.

Vol. 37 No. 39 | October 21, 2011

Download PDF Visit The Full Archive

Related Articles

BRMP Projects Priority Rated

April 11, 1980

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer

November 26, 2004

Cancer Survivors Day Planned or June 5

April 22, 1988

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013